STG-001

DB16734InvestigationalSmall molecule

STG-001 is under investigation in clinical trial NCT04489511 (Study of STG-001 in Subjects With Stargardt Disease).

Mechanism: Pharmacologically active on Retinol-binding protein 4
Curator reviewed
Formula / weight: C₁₄H₁₀F₆N₂O₂ · 352.236 g/mol (avg)
Code names: STG-001

Resolves to

Compound

Structure

InChIKeyWSFKMLQSYRCAQE-UHFFFAOYSA-NSMILESOC(=O)CCN1C=CC(=N1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with STG-001, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.